Overview
My research innovatively integrates gnotobiotic murine models, immunology, microbiology, and characterization of the microbiota with the ultimate aim of identifying specific commensal bacteria with immunomodulatory potential and subsequent characterization of their biologic effects. We have recently developed an inventive approach for identifying with high specificity organisms within the microbiota that are causally related to the phenotype of interest. Using this approach of microbe–phenotype triangulation, we identified Clostridium immunis, a new bacterial species that protects against colitis in murine models, and two bacterial species that induce host expression of a critical antimicrobial peptide. We are now investigating the molecular mechanisms—from both the bacterial and host perspectives—that underlie these host–commensal relationships. Furthermore, we are extending our discovery platform to human samples and additional disease processes to identify more causal microbes.
Current Appointments & Affiliations
Assistant Professor of Pediatrics
·
2018 - Present
Pediatrics, Infectious Diseases,
Pediatrics
Assistant Professor in the Department of Molecular Genetics and Microbiology
·
2018 - Present
Molecular Genetics and Microbiology,
Basic Science Departments
Assistant Professor of Immunology
·
2019 - Present
Integrative Immunobiology,
Basic Science Departments
Assistant Professor of Cell Biology
·
2022 - Present
Cell Biology,
Basic Science Departments
Member of the Duke Cancer Institute
·
2022 - Present
Duke Cancer Institute,
Institutes and Centers
Education, Training & Certifications
Washington University, School of Medicine ·
2006
M.D.
Washington University in St. Louis ·
2006
Ph.D.